| Medical Condition | Hypogonadism |
| Facility/Clinic | Accellacare – 1907 Tradd Ct |
| Age | 18-65 (inclusive) |
| Gender | Male |
| Description | A 12-month study providing FDA approved oral testosterone replacement therapy JATENZO in men diagnosed with hypogonadism to assess adrenal insufficiency. |
| Enrollment | Open |
| Patient Commitment Duration | 12 months |
| Number of visits in study | 13 |
| Patient Compensation | $53 per visit |
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.